
A paper clip-sized implant could reduce hospitalisations due to heart failure, bringing about a significant change in cardiac medicine, according to a new study.
The research, conducted by the Ohio State University, shows that patients receiving the implant experienced 38 per cent fewer hospitalisations in the first year.
Advertisement
"I think it's a grand slam," ABC News quoted Dr. William Abraham, one of the study's principal researchers, as saying.
He added: "It has been a decade since we have seen a trial this positive in terms of heart failure."
The device, known as the EndoSure Wireless AAA Pressure Management System, is a tiny sensor that is implanted through a catheter into the heart's pulmonary artery.
The procedure takes no more than seven minutes.
The patient has to pass a wand over his or her chest once a day to collect real-time data on heart pressure from the sensor. Thereafter, this data is sent to a secure Web site, where doctors can review it.
The implant, manufactured by CardioMEMS, doesn't run on battery and is powered by the radiofrequency wand.
The device is currently being tested as it awaits Food and Drug Administration (FDA) approval.
Source: ANI
The device, known as the EndoSure Wireless AAA Pressure Management System, is a tiny sensor that is implanted through a catheter into the heart's pulmonary artery.
Advertisement
The procedure takes no more than seven minutes.
The patient has to pass a wand over his or her chest once a day to collect real-time data on heart pressure from the sensor. Thereafter, this data is sent to a secure Web site, where doctors can review it.
The implant, manufactured by CardioMEMS, doesn't run on battery and is powered by the radiofrequency wand.
The device is currently being tested as it awaits Food and Drug Administration (FDA) approval.
Source: ANI
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Heart Disease News

58% of type 2 diabetes adults with heart failure covered by Alabama Medicaid did not receive prompt outpatient care.

The start of the week is when most fatal heart attacks occur, according to a study.

The first community-based study, published in the journal Lancet, says that delays in seeking care account for nearly 55% of the reported cardiac and stroke deaths in India.

The study emphasizes the existing proof on the heart disease risks of tobacco smoking and the urgent need to stop smoking among cancer survivors.

New study findings provide novel pathophysiological insights involving blood vessel integrity and tissue-mediated coagulation in a type of heart attack in young women.